| 000 | 01122 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511145831.0 | ||
| 264 | 0 | _c19790221 | |
| 008 | 197902s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(197811)42:5<2322::aid-cncr2820420532>3.0.co;2-e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeisenburger, D D | |
| 245 | 0 | 0 |
_aImmunoblastic lymphadenopathy associated with methyldopa therapy: a case report. _h[electronic resource] |
| 260 |
_bCancer _cNov 1978 |
||
| 300 |
_a2322-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoblastic Lymphadenopathy _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma _xpathology |
| 650 | 0 | 4 |
_aMethyldopa _xadverse effects |
| 650 | 0 | 4 |
_aSarcoma _xpathology |
| 773 | 0 |
_tCancer _gvol. 42 _gno. 5 _gp. 2322-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(197811)42:5<2322::aid-cncr2820420532>3.0.co;2-e _zAvailable from publisher's website |
| 999 |
_c739962 _d739962 |
||